IO Biotech

IO Biotech

Biotechnology Research Copenhagen, Dk 94 employees
Employees
94
Contacts
2
Emails
2
Phones
1

IO Biotech Overview

Headquarters
Copenhagen, Dk
Phone Number
Available in AeroLeads
Website
iobiotech.com
Industry
Biotechnology Research
Employees
94
Founded
2015
Funding
60.0M
Company Email
Available in AeroLeads
NAICS
Research and Development in Biotechnology (except Nanobiotechnology)

About IO Biotech

IO Biotech is a clinical-stage biopharmaceutical company developing novel, immune-modulatory, off-the-shelf therapeutic cancer vaccines based on its T-win® platform. The T-win platform is based on a novel approach to cancer vaccines designed to activate T cells to target both tumor cells and the immune-suppressive cells in the tumor microenvironment. IO Biotech is advancing its lead cancer vaccine candidate, Cylembio, in clinical trials, and additional pipeline candidates through preclinical development. IO Biotech is headquartered in Copenhagen, Denmark and has US headquarters in New York, New York. IO Biotech has an experienced management team within the immune-oncology field and a world-class advisory board.

IO Biotech Contact Details

People in AeroLeads
4
With contact data
2
Email contacts
2
50.0% coverage
Phone contacts
1
25.0% coverage

IO Biotech Org Chart

Sample employees and titles
Name Title Contact
Beth Ferguson
Email
David Smith
Email Phone
Devin Smith
View
Dr. Qasim Iftikhar Ahmad Chief Medical Officer
View

Employees by Management Level

Individual contributor 7 profiles
Manager 3 profiles
Senior / Lead 3 profiles
Executive 2 profiles
Associate / junior 2 profiles

Department Contact Coverage

Department Contacts Email Phone
General 5 5 0
Healthcare 2 2 1

IO Biotech Tech Stack

Data / AI 5 profiles

Compare Similar Companies to IO Biotech